Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 25;18(5):101055.
doi: 10.1016/j.waojou.2025.101055. eCollection 2025 May.

ARIA-Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist

Giovanni Paoletti  1   2 , Corrado Giua  3 , Alessandro Marti  1   2 , Matteo Alberto Baio  3 , Nicolò Valli  1   2 , Erminia Ridolo  4 , Maria Teresa Ventura  5   6 , Giovanni Passalacqua  7   8 , Francesca Puggioni  2 , Olga Lourenço  9 , Jean Bousquet  10   11   12 , Giorgio Walter Canonica  1   2 , Enrico Heffler  1   2 , Carlo Lombardi  13
Affiliations
Review

ARIA-Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist

Giovanni Paoletti et al. World Allergy Organ J. .

Abstract

Allergic rhinitis (AR) and asthma are common respiratory disorders that often occur together, affecting quality of life and increasing healthcare expenses of patients. These chronic illnesses are often managed without medical supervision, creating distinct challenges. A lack of resources can limit regular follow-up, which in turn promotes disease mismanagement and an increased reliance on self-medication, including the inappropriate use of corticosteroids and nasal decongestants. Community pharmacies could serve as critical primary healthcare providers, facilitating AR and asthma management by promoting therapy adherence, minimizing drug misuse, and improving symptom monitoring using digital tools. The evolving role of pharmacists as vital healthcare team members is highlighted by their involvement in screening, prevention, and patient education, particularly in underserved communities. Strengthening the partnerships between pharmacists, physicians, and patients may lead to more tailored and effective management strategies. This collaborative approach has demonstrated promise in enhancing disease outcomes and reducing healthcare costs.

Keywords: Allergic; Asthma; Patient care management; Patient care team; Pharmacists; Rhinitis.

PubMed Disclaimer

Conflict of interest statement

G.P. reports personal fees from LoFarma, GSK, Astrazeneca outside the submitted work, E. R. reports personal fees from Menarini international outside the submitted work, M.T.V. reports personal fees from Member of the board of Italian Society of Allergology, Asthma and Clinical Immunology President of the Medical Women's Italian Association- Bari outside the submitted work, F.P. reports personal fees from Sanofi, gsk, menarini, regeneron, stallergen greer, alk abello, chiesi, astrazenenca outside the submitted work, J.B.r reports personal fees from Cipla, Menarini, Mylan, Novartis, Purina, Sanofi-Aventis, Teva, Noucor, others from KYomed-Innov, others from Mask-air-SAS, outside the submitted work., G.W.C. reports personal fees from Menarini, AstraZeneca, CellTrion, Chiesi, Faes Farma, Firma, Genentech, Guidotti-Malesci, GSK, HAL Allergy, Innovacaremd, Novartis, OM-Pharma, Red Maple, Sanofi-Aventis, Sanofi-Genzyme, Stallergenes-Greer and Uriach Pharma. outside the submitted work, E.H. reports personal fees from Chiesi, Astrazeneca, Apogee therapeutics, Celltrion Healthcare, GSK, Almirall, Sanofi. Regeneron Firma, Novartis, Lofarma outside the submitted work C.L. reports personal fees from Menarini, AstraZeneca, Chiesi, Firma, GSK, Sanofi-Genzyme. outside the submitted work. A.M., N.V., G.Pas., M.A.B., C.G., O.L. don't report personal fees to declare.

Figures

Fig. 1
Fig. 1
Treatment of Allergic Rhinitis in the pharmacy. Anti-H1, Antihistamine H1 receptor antagonist; INCS, Intranasal Corticosteroid; INAH, Intranasal Antihistamine (Adapted from89).
Fig. 2
Fig. 2
The figure summarizes how the pharmacist can promote and improve the management of asthmatic and rhinitic patients through a direct approach with them. This figure was made with BioRender.com
See this image and copyright information in PMC

References

    1. Bousquet J., Khaltaev N., Cruz A.A., et al. Allergic Rhinitis and its impact on Asthma (ARIA) 2008. Allergy. 2008;63:8–160. - PubMed
    1. Passalacqua G. United airways disease: therapeutic aspects. Thorax. 2000;55:26S–27. - PMC - PubMed
    1. Bousquet J., Schünemann H.J., Togias A., et al. Next-generation allergic Rhinitis and its impact on Asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145:70–80.e3. - PubMed
    1. Nappi E., Paoletti G., Malvezzi L., et al. Comorbid allergic rhinitis and asthma: important clinical considerations. Expet Rev Clin Immunol. 2022;18:747–758. - PubMed
    1. Bousquet J., Toumi M., Sousa-Pinto B., et al. The allergic rhinitis and its impact on asthma (ARIA) approach of value-added medicines: as-needed treatment in allergic rhinitis. J Allergy Clin Immunol Pract. 2022;10:2878–2888. - PubMed

LinkOut - more resources